Asia Pac Allergy.  2012 Apr;2(2):109-114. 10.5415/apallergy.2012.2.2.109.

The role of tiotropium in the management of asthma

Affiliations
  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea. guinea71@snu.ac.kr

Abstract

Asthma is a chronic respiratory disease characterized by reversible airway obstruction that is secondary to an allergic inflammation and excessive smooth muscle contraction. Cholinergic signals were known to contribute significantly to the pathophysiology of asthma. However, the use of anti-cholinergic agents in asthma has been justified only in acute asthma exacerbations, until tiotropium bromide, a long-acting anti-cholinergic agent was introduced. Recent reports showing a promising role of tiotropium in the treatment of asthma have aroused interest of the use of anti-cholinergic agent for the management of asthma. This report describes pharmacological characteristics, potential effects on inflammatory cells, and the current status of tiotropium in the treatment of asthma.

Keyword

Anticholinergics; Asthma; Bronchodilators; Tiotropium

MeSH Terms

Airway Obstruction
Asthma*
Bronchodilator Agents
Cholinergic Antagonists
Inflammation
Muscle, Smooth
Tiotropium Bromide*
Bronchodilator Agents
Cholinergic Antagonists
Tiotropium Bromide
Full Text Links
  • APA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr